| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Higgs Stephen Dale | SVP | 1390 ENCLAVE PARKWAY, HOUSTON | /s/Andrew Wurdack, Attorney-in-Fact | 16 Mar 2026 | 0002120465 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | SYY | Common Stock | 7,935 | 06 Mar 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 9,320 | $75.08 | Direct | F1 | ||||||
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 12,126 | $72.80 | Direct | F2 | ||||||
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 13,531 | $58.08 | Direct | F3 | ||||||
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 9,754 | $76.94 | Direct | F4 | ||||||
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 6,904 | $85.57 | Direct | F5 | ||||||
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 6,130 | $73.53 | Direct | F6 | ||||||
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 3,399 | $69.95 | Direct | F7 | ||||||
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 9,580 | $76.54 | Direct | F8 | ||||||
| holding | SYY | Stock Options (Right to buy) | 06 Mar 2026 | Common Stock | 9,970 | $80.98 | Direct | F9 |
| Id | Content |
|---|---|
| F1 | One-third of the shares covered by the grant vest and are exercisable on 08/23/2019, 08/23/2020 and 08/23/2021, respectively. Options will expire on 08/22/2028. |
| F2 | One-third of the shares covered by the grant vest and are exercisable on 08/21/2020, 08/21/2021 and 08/21/2022, respectively. Options will expire on 08/20/2029. |
| F3 | One-third of the shares covered by the grant vest and are exercisable on 08/20/2021, 08/20/2022 and 08/20/2023, respectively. Options will expire on 08/19/2030. |
| F4 | One-third of the shares covered by the grant vest and are exercisable on 08/19/2022, 08/19/2023 and 08/19/2024, respectively. Options will expire on 08/18/2031. |
| F5 | One-third of the shares covered by the grant vest and are exercisable on 08/18/2023, 08/18/2024 and 08/18/2025, respectively. Options will expire on 08/17/2032. |
| F6 | One-third of the shares covered by the grant vest and are exercisable on 8/10/2024, 8/10/2025 and 8/10/2026, respectively. Options will expire on 8/9/2033. |
| F7 | One-third of the shares covered by the grant vest and are exercisable on 9/11/2024, 9/11/2025 and 9/11/2026, respectively. Options will expire on 9/10/2033. |
| F8 | One-third of the shares covered by the grant vest and are exercisable on 8/21/2025, 8/21/2026 and 8/21/2027, respectively. Options will expire on 8/20/2034. |
| F9 | Stock options granted on 8/21/2025 and become/became exercisable with respect to 33.3% of the total number of originally issued options on each of the first three anniversaries of the grant date. |